STALEVO 100*
Manufacturer Details
NOVARTIS INC
Novartis Pharmaceuticals Corp
Compositions:
Carbidopa 25mg,
Levodopa 100mg,
Entacapone 200mg Film coated tablets,
|
Strength
|
Rate
|
Packing Style
|
|
25mg+ 100mg + 200mg
|
0.00
|
250s film coated tablets
|
List of Related Indications:
List Of Drugs:
- Levodopa/Carbidopa/Entacapone - Antiparkinson Agents Combination
Indication Type Description:
Indication:
Parkinson disease
Dosages/ Overdosage Etc:
Indication-
Parkinson disease
Dosage-
The actual dosage must be determined by careful titration in each patient
Levodopa/carbidopa/ entacaprone are available in 6 strengths each with in a 1 to 4 ratio of carbidopa/
levodopa and combined with entacapone in a 200mg in a standard release formulation
Maximum dose- experience with daily doses above entacapone 1600mg is limiited.
It is recommended that no more than 1 carbidopa/levodopa/entacapone combination
is taken at each dosing administration.
Because there is limited experience with total daily doses of carbidopa greater than 300mg,the
maximum recommended daily dose of carbidopa 50mg, levodopa 200mg and entcapone 200mg
combnation is 6 tablets/day
